24
Participants
Start Date
Not specified
Primary Completion Date
October 31, 2003
Indinavir sulfate
Nelfinavir mesylate
Lamivudine
Stavudine
Michael S. Saag, Birmingham
National Institute of Allergy and Infectious Diseases (NIAID)
NIH